A unified deep learning framework for cross-platform harmonization of multi-tracer PET quantification in...

Quantitative PET underpins diagnosis and treatment monitoring in neurodegenerative disease, yet systematic biases between PET-MRI and PET-CT preclude threshold transfer and cross-site comparability. We developed and validated the first unified, anatomically guided deep-learning framework to harmonize PET-MRI quantification to PET-CT standards across multiple tracers and scanner manufacturers. The model learns CT-anchored attenuation representations using a vision transformer autoencoder, aligns MRI features to the CT space via contrastive objectives, and performs attention-guided residual correction. In paired same-day scans (N = 70; ¹⁸F-FDG, ¹⁸F-florbetaben, and ¹⁸F-florzolotau), cross-platform bias fell by >80% while preserving inter-regional biological topology. The framework generalized zero-shot to held-out tracers (¹⁸F-florbetapir and ¹⁸F-FP-CIT) without retraining. Multicenter validation (N = 420; three sites, four vendors) reduced amyloid Centiloid discrepancies from 23.6 to 4.1 (close to, though slightly above, PET-CT test-retest variability) and aligned tau SUVR thresholds. These results support more consistent cross-platform diagnostic cut-offs and reliable longitudinal monitoring when patients transition between modalities, establishing a practical route to scalable, radiation-sparing quantitative PET in therapeutic workflows.